Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals

Phase 1/2 Completed 31 enrolled NGM Biopharmaceuticals, Inc

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of NGM282 on colonic transit, bile acid homeostasis, and fecal fat in subjects with functional constipation and healthy individuals.

Timeline

Start: 2015-12
Primary completion: 2017-01
Completion: 2017-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aldafermin	Protein / enzyme biologic	—	—

Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals

Summary

Timeline

Drugs

Indications